nivolumab,ipilimumab
bms
['niche2']
only t3 and/or n+ included in niche2 #esmo22 
Heme/Onc; NHL/HL/CLL; economics in med. Adj Professor U South Carolina; Leadership/Strategy. Host of the #HealthcareUnfiltered Podcast.  https://t.co/zNtC2QILHO